{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:18:06Z","timestamp":1775607486459,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007274"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007274"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-029503"],"award-info":[{"award-number":["POCI-01-0145-FEDER-029503"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-029017"],"award-info":[{"award-number":["POCI-01-0145-FEDER-029017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["609020"],"award-info":[{"award-number":["609020"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2016123"],"award-info":[{"award-number":["2016123"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10120-020-01064-6","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T11:03:09Z","timestamp":1585134189000},"page":"811-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis"],"prefix":"10.1007","volume":"23","author":[{"given":"Nair","family":"Lopes","sequence":"first","affiliation":[]},{"given":"Christian","family":"Bergsland","sequence":"additional","affiliation":[]},{"given":"Jarle","family":"Bruun","sequence":"additional","affiliation":[]},{"given":"Merete","family":"Bj\u00f8rnslett","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9 Filipe","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Mesquita","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Rosa","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Cavadas","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Bennett","sequence":"additional","affiliation":[]},{"given":"Luisa","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Ragnhild A.","family":"Lothe","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Almeida","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4207-9258","authenticated-orcid":false,"given":"Leonor","family":"David","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"issue":"8","key":"1064_CR1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941\u201353.","journal-title":"Int J Cancer"},{"issue":"suppl 5","key":"1064_CR2","doi-asserted-by":"crossref","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38\u2013v49.","journal-title":"Ann Oncol"},{"issue":"13","key":"1064_CR3","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1073\/pnas.96.13.7318","volume":"96","author":"F Beck","year":"1999","unstructured":"Beck F, Chawengsaksophak K, Waring P, Playford RJ, Furness JB. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA. 1999;96(13):7318\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1064_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.1246","volume":"199","author":"R Almeida","year":"2003","unstructured":"Almeida R, Silva E, Santos-Silva F, Silberg DG, Wang J, De Bolos C, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol. 2003;199(1):36\u201340.","journal-title":"J Pathol"},{"issue":"2","key":"1064_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1042\/BST0380358","volume":"38","author":"R Barros","year":"2010","unstructured":"Barros R, Camilo V, Pereira B, Freund JN, David L, Almeida R. Pathophysiology of intestinal metaplasia of the stomach: emphasis on CDX2 regulation. Biochem Soc Trans. 2010;38(2):358\u201363.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"1064_CR6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.molmed.2012.07.006","volume":"18","author":"R Barros","year":"2012","unstructured":"Barros R, Freund JN, David L, Almeida R. Gastric intestinal metaplasia revisited: function and regulation of CDX2. Trends Mol Med. 2012;18(9):555\u201363.","journal-title":"Trends Mol Med"},{"issue":"3","key":"1064_CR7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/his.12544","volume":"66","author":"V Camilo","year":"2015","unstructured":"Camilo V, Garrido M, Valente P, Ricardo S, Amaral AL, Barros R, et al. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2. Histopathology. 2015;66(3):343\u201350.","journal-title":"Histopathology"},{"issue":"51","key":"1064_CR8","doi-asserted-by":"crossref","first-page":"51549","DOI":"10.1074\/jbc.M309019200","volume":"278","author":"P Mesquita","year":"2003","unstructured":"Mesquita P, Jonckheere N, Almeida R, Ducourouble MP, Serpa J, Silva E, et al. Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J Biol Chem. 2003;278(51):51549\u201356.","journal-title":"J Biol Chem"},{"key":"1064_CR9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1186\/1471-2407-14-753","volume":"14","author":"V Camilo","year":"2014","unstructured":"Camilo V, Barros R, Celestino R, Castro P, Vieira J, Teixeira MR, et al. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. BMC Cancer. 2014;14:753.","journal-title":"BMC Cancer"},{"issue":"3","key":"1064_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1506597","volume":"374","author":"P Dalerba","year":"2016","unstructured":"Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, et al. CDX2 as a prognostic biomarker in stage II and stage III colon cancer. N Engl J Med. 2016;374(3):211\u201322.","journal-title":"N Engl J Med"},{"issue":"9","key":"1064_CR11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/1878-0261.12347","volume":"12","author":"J Bruun","year":"2018","unstructured":"Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, et al. Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer. Mol Oncol. 2018;12(9):1639\u201355.","journal-title":"Mol Oncol"},{"issue":"7","key":"1064_CR12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/labinvest.2015.52","volume":"95","author":"R Pinto","year":"2015","unstructured":"Pinto R, Barros R, Pereira-Castro I, Mesquita P, da Costa LT, Bennett EP, et al. CDX2 homeoprotein is involved in the regulation of ST6GalNAc-I gene in intestinal metaplasia. Lab Invest. 2015;95(7):718\u201327.","journal-title":"Lab Invest"},{"issue":"13","key":"1064_CR13","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1093\/nar\/gkx371","volume":"45","author":"R Pinto","year":"2017","unstructured":"Pinto R, Hansen L, Hintze J, Almeida R, Larsen S, Coskun M, et al. Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression. Nucleic Acids Res. 2017;45(13):e123.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1064_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1073\/pnas.94.2.469","volume":"94","author":"JK Heath","year":"1997","unstructured":"Heath JK, White SJ, Johnstone CN, Catimel B, Simpson RJ, Moritz RL, et al. The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci USA. 1997;94(2):469\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1064_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/gast.2001.26263","volume":"121","author":"G van Niel","year":"2001","unstructured":"van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology. 2001;121(2):337\u201349.","journal-title":"Gastroenterology"},{"issue":"3","key":"1064_CR16","first-page":"465","volume":"9","author":"P Garinchesa","year":"1996","unstructured":"Garinchesa P, Sakamoto J, Welt S, Real F, Rettig W, Old L. Organ-specific expression of the colon cancer antigen A33, a cell surface target for antibody-based therapy. Int J Oncol. 1996;9(3):465\u201371.","journal-title":"Int J Oncol"},{"issue":"Suppl","key":"1064_CR17","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1007\/PL00014045","volume":"46","author":"J Sakamoto","year":"2000","unstructured":"Sakamoto J, Kojima H, Kato J, Hamashima H, Suzuki H. Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer. Cancer Chemother Pharmacol. 2000;46(Suppl):S27\u201332.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"1064_CR18","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1158\/1535-7163.MCT-18-0026","volume":"17","author":"Z Wu","year":"2018","unstructured":"Wu Z, Guo HF, Xu H, Cheung NV. Development of a tetravalent anti-GPA33\/anti-CD3 bispecific antibody for colorectal cancers. Mol Cancer Ther. 2018;17(10):2164\u201375.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"1064_CR19","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1158\/1535-7163.MCT-17-1086","volume":"17","author":"PA Moore","year":"2018","unstructured":"Moore PA, Shah K, Yang Y, Alderson R, Roberts P, Long V, et al. Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer. Mol Cancer Ther. 2018;17(8):1761\u201372.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"1064_CR20","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/gast.2002.36598","volume":"123","author":"T Hinoi","year":"2002","unstructured":"Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology. 2002;123(5):1565\u201377.","journal-title":"Gastroenterology"},{"issue":"1","key":"1064_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/gut.49.1.73","volume":"49","author":"C Grotzinger","year":"2001","unstructured":"Grotzinger C, Kneifel J, Patschan D, Schnoy N, Anagnostopoulos I, Faiss S, et al. LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut. 2001;49(1):73\u201381.","journal-title":"Gut"},{"issue":"5","key":"1064_CR22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/path.1741","volume":"205","author":"S Ko","year":"2005","unstructured":"Ko S, Chu KM, Luk JM, Wong BW, Yuen ST, Leung SY, et al. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. J Pathol. 2005;205(5):615\u201322.","journal-title":"J Pathol"},{"issue":"2","key":"1064_CR23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10620-006-9316-9","volume":"52","author":"W Dong","year":"2007","unstructured":"Dong W, Yu Q, Xu Y. Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia. Dig Dis Sci. 2007;52(2):536\u201342.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"1064_CR24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00428-005-0015-2","volume":"447","author":"R Ito","year":"2005","unstructured":"Ito R, Oue N, Yoshida K, Kunimitsu K, Nakayama H, Nakachi K, et al. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch. 2005;447(4):717\u201322.","journal-title":"Virchows Arch"},{"issue":"4","key":"1064_CR25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1440-1827.2006.01946.x","volume":"56","author":"J Motoshita","year":"2006","unstructured":"Motoshita J, Nakayama H, Taniyama K, Matsusaki K, Yasui W. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype. Pathol Int. 2006;56(4):200\u20135.","journal-title":"Pathol Int"},{"issue":"1","key":"1064_CR26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1245\/s10434-006-9114-9","volume":"14","author":"SS Park","year":"2007","unstructured":"Park SS, Kang SH, Park JM, Kim JH, Oh SC, Lee JH, et al. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively? Ann Surg Oncol. 2007;14(1):94\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1064_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clon.2008.01.013","volume":"20","author":"J Ge","year":"2008","unstructured":"Ge J, Chen Z, Wu S, Yuan W, Hu B, Chen Z. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. Clin Oncol (R Coll Radiol). 2008;20(4):275\u201383.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"1064_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/j.gastro.2010.04.008","volume":"139","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, et al. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology. 2010;139(1):213\u201325.e3.","journal-title":"Gastroenterology"},{"issue":"2","key":"1064_CR29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1309\/AJCPKSHXI3XEHW1J","volume":"138","author":"NC Panarelli","year":"2012","unstructured":"Panarelli NC, Yantiss RK, Yeh MM, Liu Y, Chen YT. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Am J Clin Pathol. 2012;138(2):211\u201322.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"1064_CR30","doi-asserted-by":"crossref","first-page":"e85296","DOI":"10.1371\/journal.pone.0085296","volume":"9","author":"Z Lin","year":"2014","unstructured":"Lin Z, Zhang C, Zhang M, Xu D, Fang Y, Zhou Z, et al. Targeting cadherin-17 inactivates Ras\/Raf\/MEK\/ERK signaling and inhibits cell proliferation in gastric cancer. PLoS ONE. 2014;9(1):e85296.","journal-title":"PLoS ONE"},{"issue":"1","key":"1064_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3892\/ijo.2016.3783","volume":"50","author":"R Li","year":"2017","unstructured":"Li R, Yang HQ, Xi HL, Feng S, Qin RH. Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells. Int J Oncol. 2017;50(1):15\u201322.","journal-title":"Int J Oncol"},{"issue":"3","key":"1064_CR32","doi-asserted-by":"crossref","first-page":"e56959","DOI":"10.1371\/journal.pone.0056959","volume":"8","author":"HB Qiu","year":"2013","unstructured":"Qiu HB, Zhang LY, Ren C, Zeng ZL, Wu WJ, Luo HY, et al. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt\/beta-catenin signaling. PLoS ONE. 2013;8(3):e56959.","journal-title":"PLoS ONE"},{"issue":"3","key":"1064_CR33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4161\/cbt.23299","volume":"14","author":"J Wang","year":"2013","unstructured":"Wang J, Kang WM, Yu JC, Liu YQ, Meng QB, Cao ZJ. Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFkappaB signaling pathway. Cancer Biol Ther. 2013;14(3):262\u201370.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1064_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41374-019-0336-4","volume":"100","author":"N Lopes","year":"2020","unstructured":"Lopes N, Bergsland CH, Bjornslett M, Pellinen T, Svindland A, Nesbakken A, et al. Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Lab Invest. 2020;100(1):120\u201334.","journal-title":"Lab Invest"},{"issue":"12","key":"1064_CR35","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.ejca.2005.03.032","volume":"41","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer. 2005;41(12):1690\u20136.","journal-title":"Eur J Cancer"},{"key":"1064_CR36","unstructured":"Team RC. R: A language and environment for statistical computing. 2017. https:\/\/www.R-project.org. Accessed Aug 2019."},{"issue":"37","key":"1064_CR37","doi-asserted-by":"crossref","first-page":"34531","DOI":"10.1074\/jbc.M204865200","volume":"277","author":"CN Johnstone","year":"2002","unstructured":"Johnstone CN, White SJ, Tebbutt NC, Clay FJ, Ernst M, Biggs WH, et al. Analysis of the regulation of the A33 antigen gene reveals intestine-specific mechanisms of gene expression. J Biol Chem. 2002;277(37):34531\u20139.","journal-title":"J Biol Chem"},{"issue":"28","key":"1064_CR38","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1038\/sj.onc.1206508","volume":"22","author":"Z Mao","year":"2003","unstructured":"Mao Z, Song S, Zhu Y, Yi X, Zhang H, Shang Y, et al. Transcriptional regulation of A33 antigen expression by gut-enriched Kruppel-like factor. Oncogene. 2003;22(28):4434\u201343.","journal-title":"Oncogene"},{"issue":"6","key":"1064_CR39","first-page":"1234","volume":"21","author":"LP Qu","year":"2017","unstructured":"Qu LP, Zhong YM, Zheng Z, Zhao RX. CDH17 is a downstream effector of HOXA13 in modulating the Wnt\/beta-catenin signaling pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 2017;21(6):1234\u201341.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"1064_CR40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jcb.22742","volume":"111","author":"R Zhu","year":"2010","unstructured":"Zhu R, Wong KF, Lee NP, Lee KF, Luk JM. HNF1alpha and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma. J Cell Biochem. 2010;111(3):618\u201326.","journal-title":"J Cell Biochem"},{"issue":"12","key":"1064_CR41","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/ijc.24683","volume":"125","author":"J Rageul","year":"2009","unstructured":"Rageul J, Mottier S, Jarry A, Shah Y, Theoleyre S, Masson D, et al. KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines. Int J Cancer. 2009;125(12):2802\u20139.","journal-title":"Int J Cancer"},{"issue":"9","key":"1064_CR42","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1349-7006.2012.02353.x","volume":"103","author":"N Sakamoto","year":"2012","unstructured":"Sakamoto N, Oue N, Sentani K, Anami K, Uraoka N, Naito Y, et al. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer. Cancer Sci. 2012;103(9):1744\u201350.","journal-title":"Cancer Sci"},{"issue":"5","key":"1064_CR43","doi-asserted-by":"crossref","first-page":"dev172189","DOI":"10.1242\/dev.172189","volume":"146","author":"N Kumar","year":"2019","unstructured":"Kumar N, Tsai YH, Chen L, Zhou A, Banerjee KK, Saxena M, et al. The lineage-specific transcription factor CDX2 navigates dynamic chromatin to control distinct stages of intestine development. Development. 2019;146(5):dev172189.","journal-title":"Development"},{"issue":"4","key":"1064_CR44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4166\/kjg.2012.60.4.229","volume":"60","author":"KH Ryu","year":"2012","unstructured":"Ryu KH, Shim KN, Jung SA, Yoo K, Joo YH, Lee JH. Significance of preoperative tissue levels of vascular-endothelial cadherin, liver-intestine cadherin and vascular endothelial growth factor in gastric cancer. Korean J Gastroenterol. 2012;60(4):229\u201341.","journal-title":"Korean J Gastroenterol"},{"issue":"39","key":"1064_CR45","doi-asserted-by":"crossref","first-page":"64168","DOI":"10.18632\/oncotarget.11638","volume":"7","author":"K Matsusaka","year":"2016","unstructured":"Matsusaka K, Ushiku T, Urabe M, Fukuyo M, Abe H, Ishikawa S, et al. Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer. Oncotarget. 2016;7(39):64168\u201381.","journal-title":"Oncotarget"},{"issue":"24","key":"1064_CR46","doi-asserted-by":"crossref","first-page":"17056","DOI":"10.18632\/oncotarget.24842","volume":"9","author":"Y Shigematsu","year":"2018","unstructured":"Shigematsu Y, Inamura K, Mise Y, Saiura A, Rehnberg E, Yamamoto N, et al. CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan. Oncotarget. 2018;9(24):17056\u201365.","journal-title":"Oncotarget"},{"issue":"3","key":"1064_CR47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/gut.2010.222323","volume":"60","author":"R Barros","year":"2011","unstructured":"Barros R, da Costa LT, Pinto-de-Sousa J, Duluc I, Freund JN, David L, et al. CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype. Gut. 2011;60(3):290\u20138.","journal-title":"Gut"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-020-01064-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-020-01064-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-020-01064-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T01:03:42Z","timestamp":1616634222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-020-01064-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s10120-020-01064-6","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]},"assertion":[{"value":"4 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent to be included in the study, or the equivalent, was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The use of retrospective samples from which informed consent cannot be obtained is authorised for research studies by the Portuguese law. Recent samples included in the study had written informed consent. The study was approved by Centro Hospitalar S\u00e3o Jo\u00e3o ethics committee under the reference number CES 122-15.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}